Sanofi (NASDAQ:SNY – Get Free Report) will likely be issuing its quarterly earnings data before the market opens on Thursday, January 30th. Analysts expect the company to announce earnings of $0.70 per share and revenue of $10.57 billion for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.
Sanofi Stock Performance
NASDAQ SNY opened at $52.97 on Wednesday. The firm’s fifty day moving average price is $48.90 and its two-hundred day moving average price is $52.22. The stock has a market cap of $134.43 billion, a PE ratio of 27.03, a PEG ratio of 1.19 and a beta of 0.57. Sanofi has a fifty-two week low of $45.22 and a fifty-two week high of $58.97. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.65 and a current ratio of 1.00.
Wall Street Analyst Weigh In
Separately, StockNews.com cut shares of Sanofi from a “buy” rating to a “hold” rating in a research note on Thursday, December 12th.
Sanofi Company Profile
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.
Read More
- Five stocks we like better than Sanofi
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- How to Find Undervalued Stocks
- What Does the Future Hold for Eli Lilly?
- How to Calculate Inflation Rate
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.